To address systemic inequities in pediatric care as precision medicine evolves, ensuring that advancements benefit all children, particularly those from marginalized communities.
Approach:
PCH Equity Framework: Proposes a framework that expands the definition of precision medicine through an equity lens, focusing on equitable access, participation, benefit, and governance of precision health innovations.
Key Findings:
Many children globally face barriers to accessing healthcare and precision medicine.
Precision medicine initiatives often disproportionately benefit privileged populations.
Structural inequities shape access to genetic testing and therapies.
Historical mistrust affects participation from marginalized communities in precision medicine.
The PCH Equity framework aims to integrate social, structural, and environmental factors into precision medicine.
Interpretation:
Equity must be intentionally integrated into precision medicine to prevent widening existing disparities in pediatric care.
Limitations:
Current precision medicine initiatives may neglect broader social and economic conditions affecting health.
Data used in genetic research often lacks diversity, reinforcing existing biases.
Conclusion:
Embedding equity in precision medicine is essential to ensure that all children benefit from advancements in healthcare.
